Nestle India’s Q3 results are anticipated to show steady revenue growth. Strong domestic sales are expected to drive this performance. However, rising input costs may impact profitability. Analysts predict a modest year-on-year profit increase. The company’s focus remains on volume expansion and innovation for long-term growth. Investors will monitor commentary on commodity prices.
Market bets on Aurobindo as Europe, US Sales show uptick
Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also developing weight loss